Mizuho Trust & Banking’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-2,197,138
Closed -$174M 284
2016
Q3
$174M Sell
2,197,138
-25,680
-1% -$2.09M 0.51% 41
2016
Q2
$185M Sell
2,222,818
-101,194
-4% -$8.98M 0.57% 39
2016
Q1
$213M Buy
2,324,012
+46,348
+2% +$4.18M 0.68% 34
2015
Q4
$233M Buy
2,277,664
+23,105
+1% +$2.4M 0.77% 27
2015
Q3
$221M Buy
2,254,559
+59,135
+3% +$6.57M 0.77% 24
2015
Q2
$257M Buy
2,195,424
+39,650
+2% +$4.33M 0.85% 20
2015
Q1
$212M Buy
2,155,774
+146,395
+7% +$14.9M 0.72% 27
2014
Q4
$189M Buy
2,009,379
+78,081
+4% +$8.08M 0.67% 31
2014
Q3
$206M Sell
1,931,298
-129,974
-6% -$12.7M 0.78% 23
2014
Q2
$171M Sell
2,061,272
-19,918
-1% -$1.55M 0.61% 33
2014
Q1
$147M Sell
2,081,190
-19,719
-0.9% -$1.55M 0.55% 37
2013
Q4
$158M Buy
2,100,909
+10,044
+0.5% +$699K 0.6% 36
2013
Q3
$107M Hold
2,090,865
0.45% 43
2013
Q2
$107M Buy
+2,090,865
New +$109M 0.45% 41

Other funds holding GILD

Mizuho Trust & Banking's GILD Position: Q4 2016 in Review

Mizuho Trust & Banking sold out of Gilead Sciences (GILD) in Q4 2016, closing a stake of 2,197,138 shares — an estimated $174M sold.

Mizuho Trust & Banking first reported a position in GILD in Q2 2013 and held it in 14 quarters. The position peaked at $257M in Q2 2015. 1,572 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

  • Mizuho Trust & Banking reported no remaining Gilead Sciences position as of Q4 2016 after selling out during the quarter.
  • Mizuho Trust & Banking sold 2,197,138 Gilead Sciences shares in Q4 2016, an estimated $174M.
  • Mizuho Trust & Banking first reported a position in Gilead Sciences in Q2 2013 and held it in 14 quarters.
  • Mizuho Trust & Banking's Gilead Sciences position peaked at $257M in Q2 2015.
  • 1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Mizuho Trust & Banking's 13F filing for Q4 2016, filed 14 Feb 2017.